微信公众号
证券之星APP
| 报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | 48.19% | 8.99% | 5.68% | 80/157 | 50.55% | 泽璟制药 | 94.64% | 行业排名> |
| 2025-12-31 | 45.6% | 9.95% | 0.04% | 84/157 | 50.61% | 海创药业 | 99.82% | 行业排名> |
| 2025-09-30 | 45.58% | 10.19% | 2.38% | 85/157 | -2.2% | 海创药业 | 98.62% | 行业排名> |
| 2025-06-30 | 44.52% | 8.7% | 0.7% | 86/157 | 14.83% | 海创药业 | 99.57% | 行业排名> |
| 2025-03-31 | 44.21% | 13.05% | 6.61% | 83/157 | 31.96% | 海创药业 | 99.52% | 行业排名> |
| 2024-12-31 | 41.47% | 0.96% | 0.25% | 99/157 | 51.88% | 艾力斯 | 96.74% | 行业排名> |
| 2024-09-30 | 41.37% | 3.24% | 0.99% | 94/157 | 22.51% | 首药控股 | 98.96% | 行业排名> |
| 2024-06-30 | 40.96% | 5.08% | 4.74% | 93/157 | 33.12% | 迪哲医药 | 97.73% | 行业排名> |
| 2024-03-31 | 39.11% | 5.69% | -4.8% | 96/157 | 51.76% | 百利天恒 | 97.99% | 行业排名> |
| 2023-12-31 | 41.08% | 9.95% | 2.52% | 101/157 | 51.61% | 百利天恒 | 98.92% | 行业排名> |
| 2023-09-30 | 40.07% | 2% | 2.79% | 104/157 | 32.47% | 迈威生物 | 98.93% | 行业排名> |
| 2023-06-30 | 38.98% | 3.01% | 5.35% | 106/157 | 38.42% | 迈威生物 | 99.59% | 行业排名> |
| 2023-03-31 | 37% | 2% | -0.96% | 105/157 | 52.97% | 迈威生物 | 99.8% | 行业排名> |
| 2022-12-31 | 37.36% | -6.54% | -1.28% | 107/157 | 53.83% | 迈威生物 | 99.46% | 行业排名> |
| 2022-06-30 | 37.84% | -3.62% | -5.33% | 105/157 | 20.99% | 迈威生物 | 99.75% | 行业排名> |
| 2021-12-31 | 39.98% | 1.6% | 1.8% | 104/157 | 55.2% | 迈威生物 | 99.67% | 行业排名> |
| 2021-06-30 | 39.27% | 2% | -0.2% | 103/157 | 47.23% | 迈威生物 | 99.44% | 行业排名> |
| 2020-12-31 | 39.35% | -18.08% | -18.08% | 105/157 | -148.64% | 迈威生物 | 98.57% | 行业排名> |
| 2019-12-31 | 48.03% | 0.68% | 0.68% | 81/157 | -1242.15% | 首药控股 | 99.93% | 行业排名> |
| 2018-12-31 | 47.71% | 2% | 2% | 75/157 | -211.97% | 艾力斯 | 99.41% | 行业排名> |